Highlights and Quick Summary
- Research and Development (R&D) Expenses Growth for the quarter ending June 30, 2023 was 26.71% (a -18.91% decrease compared to previous quarter)
- Year-over-year quarterly Research and Development (R&D) Expenses Growth decreased by -629.96%
- Annual Research and Development (R&D) Expenses Growth for 2022 was 17.68% (a -89.5% decrease from previous year)
- Annual Research and Development (R&D) Expenses Growth for 2021 was 168.38% (a -45.58% decrease from previous year)
- Annual Research and Development (R&D) Expenses Growth for 2020 was 309.42% (a 95.76% increase from previous year)
- Twelve month Research and Development (R&D) Expenses Growth ending June 30, 2023 was 7.04% (a -56.41% decrease compared to previous quarter)
- Twelve month trailing Research and Development (R&D) Expenses Growth decreased by -85.98% year-over-year
Trailing Research and Development (R&D) Expenses Growth for the last four month:
| 30 Jun '23 | 31 Mar '23 | 31 Dec '22 | 30 Sep '22 |
|---|---|---|---|
| 7.04% | 16.15% | 17.68% | 50.21% |
Visit stockrow.com/DYN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Research and Development (R&D) Expenses Growth of Dyne Therapeutics, Inc.
Most recent Research and Development (R&D) Expenses Growthof DYN including historical data for past 10 years.Interactive Chart of Research and Development (R&D) Expenses Growth of Dyne Therapeutics, Inc.
Dyne Therapeutics, Inc. Research and Development (R&D) Expenses Growth for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | 26.71% | 32.94% | – | – | – |
| 2022 | -21.54% | -5.04% | 95.48% | 51.6% | 17.68% |
| 2021 | 91.42% | 277.21% | 225.5% | 205.88% | 168.38% |
| 2020 | 641.05% | -73.49% | -69.28% | -67.31% | 309.42% |
| 2019 | – | – | – | -86.51% | 158.06% |
| 2018 | – | – | – | – | -61.25% |
Business Profile of Dyne Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology